
Cytokinetics, Incorporated CYTK
$ 65.43
0.75%
Annual report 2025
added 02-26-2026
Cytokinetics, Incorporated P/S Ratio 2011-2026 | CYTK
Annual P/S Ratio Cytokinetics, Incorporated
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.0857 | 0.286 | 0.944 | 0.0411 | 0.0498 | 0.024 | 27.6 | 12 | 34 | 3.77 | 10.4 | 5.39 | 7.15 | 15.8 | 18.4 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 34 | 0.024 | 9.06 |
P/S Ratio of other stocks in the Biotechnology industry
| Issuer | P/S Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
1.75 | - | 2.43 % | $ 254 M | ||
|
I-Mab
IMAB
|
94.1 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
1.96 K | - | 2.54 % | $ 160 B | ||
|
Autolus Therapeutics plc
AUTL
|
4.27 | $ 1.36 | -2.15 % | $ 362 M | ||
|
Midatech Pharma plc
MTP
|
137 | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K | - | -1.52 % | $ 24.7 M | ||
|
Acorda Therapeutics
ACOR
|
0.142 | - | -24.86 % | $ 820 K | ||
|
Alterity Therapeutics Limited
ATHE
|
131 | $ 3.78 | 4.83 % | $ 9.09 B | ||
|
Advaxis
ADXS
|
144 | - | -9.65 % | $ 45.9 M | ||
|
Adverum Biotechnologies
ADVM
|
76.4 | - | - | $ 86.2 M | ||
|
Aytu BioScience
AYTU
|
0.237 | $ 2.6 | -2.26 % | $ 16.3 M | ||
|
Институт стволовых клеток человека
ISKJ
|
2.61 | - | - | - | ||
|
Aeterna Zentaris
AEZS
|
7.87 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
0.099 | - | -10.17 % | $ 12.2 K | ||
|
Aeglea BioTherapeutics
AGLE
|
489 | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
65.5 | - | - | $ 26.5 M | ||
|
AIkido Pharma
AIKI
|
0.935 | - | 1.93 % | $ 17.4 M | ||
|
CureVac N.V.
CVAC
|
281 | - | - | $ 867 M | ||
|
BioNTech SE
BNTX
|
35.7 | $ 88.33 | -3.24 % | $ 27.2 B | ||
|
Coherus BioSciences
CHRS
|
5.36 | $ 1.62 | -2.99 % | $ 190 M | ||
|
Alnylam Pharmaceuticals
ALNY
|
11 | $ 317.48 | -3.89 % | $ 41.6 B | ||
|
Alpine Immune Sciences
ALPN
|
8.94 | - | - | $ 2.17 B | ||
|
Burford Capital Limited
BUR
|
6.35 | $ 4.5 | 0.67 % | $ 729 M | ||
|
Ampio Pharmaceuticals
AMPE
|
106 | - | -11.43 % | $ 502 K | ||
|
IDEAYA Biosciences
IDYA
|
12.5 | $ 31.06 | -3.96 % | $ 2.75 B | ||
|
argenx SE
ARGX
|
311 | $ 755.85 | 1.02 % | $ 25 B | ||
|
Завод ДИОД
DIOD
|
1.28 | - | - | - | ||
|
Фармсинтез
LIFE
|
5.39 | - | - | - | ||
|
Aptorum Group Limited
APM
|
105 | $ 0.89 | 0.54 % | $ 4.85 M | ||
|
Applied Therapeutics
APLT
|
54.1 | - | - | $ 8.42 M | ||
|
Aptinyx
APTX
|
204 | - | -39.0 % | $ 4.57 M | ||
|
Teligent, Inc.
TLGT
|
0.111 | - | -13.85 % | $ 16.1 M | ||
|
Cerus Corporation
CERS
|
2.12 | $ 1.85 | - | $ 353 M | ||
|
AbbVie
ABBV
|
24.1 | $ 204.25 | -1.15 % | $ 361 B | ||
|
Aquestive Therapeutics
AQST
|
10.5 | $ 4.03 | -1.59 % | $ 431 M | ||
|
Aravive
ARAV
|
6.61 | - | -13.39 % | $ 1.45 M | ||
|
Viela Bio, Inc.
VIE
|
36.6 | - | - | $ 2.91 B | ||
|
AbCellera Biologics
ABCL
|
12.8 | $ 3.26 | -3.98 % | $ 974 M |